Total Payments
$9,762
2024 Payments
$1,178
Companies
38
Transactions
388
Medicare Patients
4,372
Medicare Billing
$419,863
Payment Breakdown by Category
Food & Beverage$8,656 (88.7%)
Travel$1,091 (11.2%)
Education$15.18 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,656 | 381 | 88.7% |
| Travel and Lodging | $1,091 | 6 | 11.2% |
| Education | $15.18 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $4,814 | 145 | $0 (2024) |
| TerSera Therapeutics LLC | $572.78 | 31 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $458.69 | 40 | $0 (2024) |
| Curonix LLC | $364.81 | 4 | $0 (2024) |
| Medtronic, Inc. | $339.60 | 3 | $0 (2024) |
| Nevro Corp. | $317.31 | 9 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $308.56 | 30 | $0 (2021) |
| SI-BONE, INC. | $267.92 | 8 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $184.35 | 10 | $0 (2018) |
| Averitas Pharma Inc. | $180.07 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,178 | 30 | Curonix LLC ($364.81) |
| 2023 | $2,477 | 47 | Boston Scientific Corporation ($1,682) |
| 2022 | $872.26 | 33 | Boston Scientific Corporation ($475.45) |
| 2021 | $899.81 | 37 | BOSTON SCIENTIFIC CORPORATION ($418.55) |
| 2020 | $983.98 | 40 | Boston Scientific Corporation ($747.08) |
| 2019 | $1,395 | 73 | Boston Scientific Corporation ($522.65) |
| 2018 | $919.13 | 54 | BOSTON SCIENTIFIC CORPORATION ($373.79) |
| 2017 | $1,037 | 74 | BOSTON SCIENTIFIC CORPORATION ($471.81) |
All Payment Transactions
388 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/14/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Pain Management | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/10/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: Pain Management | ||||||
| 09/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/29/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $30.31 | General |
| 08/08/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Pain Management | ||||||
| 08/06/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/01/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/07/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/31/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/16/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Pain Management | ||||||
| 05/04/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: Opioid Analgesic | ||||||
| 04/25/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Pain Management | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Gastroenterology | ||||||
| 04/03/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $54.40 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 03/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/27/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/24/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Travel and Lodging | Cash or cash equivalent | $33.83 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/24/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $33.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/23/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Travel and Lodging | Cash or cash equivalent | $181.26 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/23/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $115.90 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 905 | 4,325 | $355,942 | $76,735 |
| 2022 | 19 | 931 | 4,473 | $394,733 | $83,951 |
| 2021 | 18 | 1,206 | 4,745 | $444,752 | $127,194 |
| 2020 | 19 | 1,330 | 4,163 | $444,252 | $131,982 |
Total Patients
4,372
Total Services
17,706
Medicare Billing
$419,863
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 88 | 88 | $25,240 | $13,546 | 53.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 54 | 61 | $58,500 | $12,675 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 187 | $25,116 | $11,783 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 83 | $15,355 | $6,806 | 44.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 73 | 83 | $26,975 | $6,050 | 22.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 36 | 60 | $27,270 | $5,441 | 20.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 54 | 61 | $23,400 | $4,016 | 17.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 37 | 45 | $57,750 | $3,384 | 5.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 42 | 58 | $11,400 | $3,115 | 27.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 36 | 60 | $14,140 | $3,097 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $3,990 | $2,354 | 59.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 14 | 17 | $9,680 | $1,571 | 16.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 17 | 19 | $2,565 | $765.32 | 29.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 14 | 17 | $6,490 | $733.78 | 11.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 27 | 28 | $990.00 | $546.44 | 55.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,162 | $513.97 | 44.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Facility | 2023 | 142 | 2,742 | $37,017 | $265.18 | 0.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 45 | 648 | $8,748 | $58.55 | 0.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 16 | 36 | $154.08 | $14.76 | 9.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 68 | 80 | $74,000 | $16,771 | 22.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 83 | 83 | $22,822 | $13,141 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 106 | $18,556 | $8,782 | 47.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 47 | 85 | $41,310 | $8,045 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 123 | $13,284 | $6,952 | 52.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2022 | 69 | 82 | $30,000 | $5,242 | 17.5% |
About Dr. Mark Bell, M.D
Dr. Mark Bell, M.D is a Interventional Pain Medicine healthcare provider based in Plains, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497755631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bell, M.D has received a total of $9,762 in payments from pharmaceutical and medical device companies, with $1,178 received in 2024. These payments were reported across 388 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($8,656).
As a Medicare-enrolled provider, Bell has provided services to 4,372 Medicare beneficiaries, totaling 17,706 services with total Medicare billing of $419,863. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Plains, PA
- Active Since 07/29/2005
- Last Updated 10/14/2013
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1497755631
Products in Payments
- INFINION (Device) $915.76
- GENERAL - PAIN MANAGEMENT (Device) $657.08
- Prialt (Drug) $541.00
- XTAMPZA (Drug) $403.12
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $364.81
- WaveWriter Alpha Prime 16 (Device) $338.62
- SPECTRA WAVEWRITER (Device) $301.09
- GENERAL PAIN MANAGEMENT (Device) $234.61
- INFINION LEAD TRIAL (Device) $220.13
- PRIALT (Drug) $216.13
- Infinion 16 (Device) $200.29
- VANTA ADAPTIVESTIM (Device) $200.10
- BELBUCA (Drug) $199.95
- BOTOX (Biological) $188.41
- Senza (Device) $187.78
- iFuse Implant (Device) $181.88
- QUTENZA (Drug) $180.07
- General - Pain Management (Device) $171.40
- GENERAL PAIN MANAGEMENT (Device) $153.13
- Zilretta (Drug) $149.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.